Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01976585
Title In Situ Vaccine for Low-Grade Lymphoma: Combination of Intratumoral Flt3L and Poly-ICLC With Low-Dose Radiotherapy
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Joshua Brody
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.